| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $62.3M | +2.3% |
| SG&A Expense | $27.4M | -2.0% |
| Operating Income | -$89.7M | -0.9% |
| Income Tax | $0 | — |
| Net Income | -$84.3M | -2.0% |
| EPS (Basic) | -$2.07 | +2.8% |
| EPS (Diluted) | -$2.07 | +2.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.0M | -25.0% |
| Short-term Investments | $58.8M | -10.9% |
| Current Assets | $100.6M | -17.5% |
| Total Assets | $117.7M | -16.4% |
| Current Liabilities | $34.1M | +192.8% |
| Total Liabilities | $46.1M | +87.2% |
| Stockholders' Equity | $71.6M | -38.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.2M | +27.2% |
| Capital Expenditures | $5K | -99.3% |
| Investing Cash Flow | $8.8M | +113.4% |
| Financing Cash Flow | $29.5M | +3220.9% |
| Free Cash Flow | -$51.2M | +27.9% |